Theradiag SA
PAR:ALTER

Watchlist Manager
Theradiag SA Logo
Theradiag SA
PAR:ALTER
Watchlist
Price: 1.26 EUR Market Closed
Market Cap: 16.4m EUR
Have any thoughts about
Theradiag SA?
Write Note

Wall Street
Price Targets

ALTER Price Targets Summary
Theradiag SA

There are no price targets for ALTER.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Theradiag SA Competitors:
Price Targets
SUS
Surgical Science Sweden AB
23% Upside
6849
Nihon Kohden Corp
10% Upside
CLPT
Clearpoint Neuro Inc
6% Upside
PDEX
Pro-Dex Inc
9% Upside
300529
Jafron Biomedical Co Ltd
43% Upside
BRETEC
Bioretec Oy
9% Upside
SIBN
SI-BONE Inc
68% Upside
AXNX
Axonics Inc
3% Upside

Revenue
Forecast

Revenue Estimate
Theradiag SA

For the last 8 years the compound annual growth rate for Theradiag SA's revenue is 6%. The projected CAGR for the next 3 years is 15%.

6%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Theradiag SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

Net Income
Forecast

Net Income Estimate
Theradiag SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALTER's stock price target?
Not Available

ALTER doesn't have any price targets made by Wall Street professionals.

What is Theradiag SA's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Theradiag SA's revenue is 6%. The projected CAGR for the next 3 years is 15%.

Back to Top